Data / Form D filings / Precision Biologics, Inc.
Precision Biologics, Inc.: Form D filings
Precision Biologics, Inc., a biotechnology company in Rockville, MD, filed 6 Form D notices with the SEC between 2012 and 2015. The latest, on October 19, 2015, reports $53.1 million sold of a $53.1 million offering to 34 investors.
Find out what Precision Biologics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 11300 Rockville Pike, Suite 1140, Rockville, MD, 20852
- Phone
- (301) 917-6890
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2012
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1560075
The full lists. Form D filings in Maryland: 608 rows, $30.40, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 19, 2015 | New notice | $53,096,422 | $53,096,422 | $0 | 34 | Oct 2, 2015 | sec.gov |
| Apr 2, 2014 | New notice | $2,400,000 | $795,000 | $1,605,000 | 11 | Dec 19, 2013 | sec.gov |
| Dec 16, 2013 | New notice | $12,750,000 | $10,500,000 | $2,250,000 | 14 | Nov 25, 2013 | sec.gov |
| May 21, 2013 | Amendment | $7,500,000 | $3,289,327 | $4,210,673 | 85 | Mar 31, 2013 | sec.gov |
| May 21, 2013 | New notice | $5,000,000 | $2,192,885 | $2,807,115 | 85 | Mar 31, 2013 | sec.gov |
| Oct 11, 2012 | New notice | $5,313,075 | $5,313,075 | $0 | 30 | Sep 24, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Patrick M. Soon-Shiong | Director | |
| Stanley B. Archibald, Jr. | Director, Promoter | |
| R.J. B. Childress | Executive Officer | |
| Christian M. Zapf | Director | |
| Charles M. Kim | Director | |
| Philip M. Arlen | Executive Officer, Director |
Other biotechnology companies in Maryland that filed recently
- BlueHealer Inc. $1 · Nov 4, 2026
- Accufy Diagnostics, Inc. $2 million · Oct 28, 2026
- OS Therapies Inc $7.2 million · Oct 23, 2026
- Kaigene, Inc. $55 million · Oct 14, 2026
- Templar Nova, Inc. $7 million · Oct 7, 2026
- Monocacy Therapeutics Inc. $25,000 · Oct 7, 2026
- Seraxis Holdings, Inc. $10 million · Sep 24, 2026
- Uvantis Therapeutics, Inc. $100,000 · Sep 23, 2026
- Gliknik Inc $15 million · Sep 17, 2026
- Georgiamune, Inc. $92.7 million · Aug 17, 2026
Every Form D from the week of Oct 19, 2015 · All recent filings in Maryland · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Precision Biologics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.